GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
Mar2024 | |
---|---|
PCE(x) | 27.53 |
What is the latest Price to Cash Earnings (PCE) ratio of GUFIC BIOSCIENCES ?
Year | Price to Cash Earnings (PCE) |
---|---|
Mar2024 | 27.53 |
How is Price to Cash Earnings (PCE) of GUFIC BIOSCIENCES Trending?
Years | Price to Cash Earnings (PCE) | % Change | |
---|---|---|---|
Mar2024 | 27.53 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,836.0 Cr | 3.4% | 7.4% | 9.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,509.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹118,336.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,522.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | 3.4% |
7.4% |
9.3% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses